NEW YORK (GenomeWeb News) – WaferGen today reported that its first-quarter revenues tripled and its net loss nearly doubled for the three-month period ended March 31.
 
The Fremont, Calif.-based firm also announced that it has signed two private placements that could bring in close to $6 million in funding.
 
WaferGen, which makes the SmartChip Real-Time PCR System, brought in Q1 revenues of $181,640, compared to 2007 first-quarter revenues of $60,460.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.